Production & Manufacturing

FDA Approves Janssen’s STELARA for Treatment of Adults With...

Janssen Biotech Inc announced that the U.S. FDA has approved STELARA® (ustekinumab) for the treatment of moderately to severely active Crohn’s disease in adults (18...

Alcon launches the NGENUITY® 3D Visualization System designed to...

Alcon, the global leader in eye care and a division of Novartis, launches the NGENUITY® 3D Visualization System, a platform for Digitally Assisted Vitreoretinal Surgery...

GSK announces positive real-world data for meningitis B vaccine...

Preliminary data from the world’s first national meningitis B immunisation programme with Bexsero1, launched one year ago in the UK, shows the estimated effectiveness of...

Dr. Reddy’s Laboratories announces the launch of Bupropion HCl...

Dr. Reddy’s Laboratories Ltd announced that it has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic...

AstraZeneca enters commercialisation agreement with Aspen for  anaesthetics portfolio

AstraZeneca announced that it has completed the commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics...

TaiGen Biotechnology Out-Licenses Taigexyn® (Nemonoxacin) to Productos Científicos for...

TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Productos Científicos S.A. de C.V. ("PC"), a leading Mexican pharmaceutical company,...

Janssen Submits Application to U.S. FDA to Expand Indication...

Janssen Biotech, Inc. announced a supplemental Biologics License Application (sBLA) for daratumumab (DARZALEX®) has been submitted to the U.S. FDA . The...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read